Skip to main content
Erschienen in: Digestive Diseases and Sciences 8/2019

09.03.2019 | Original Article

Positive Association Between Helicobacter pylori Infection and Metabolic Syndrome in a Korean Population: A Multicenter Nationwide Study

verfasst von: Seon Hee Lim, Nayoung Kim, Jin Won Kwon, Sung Eun Kim, Gwang Ho Baik, Ju Yup Lee, Kyung Sik Park, Jeong Eun Shin, Hyun Joo Song, Dae-Seong Myung, Suck Chei Choi, Hyun Jin Kim, Joo Hyun Lim, Jeong Yoon Yim, Joo Sung Kim

Erschienen in: Digestive Diseases and Sciences | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Background and Aim

Helicobacter pylori (H. pylori) infection causes extra-gastrointestinal as well as gastric diseases. This analytical cross-sectional study was performed to investigate the association between H. pylori infection and metabolic syndrome in a Korean population.

Methods

Anthropometric and metabolic data, as well as anti-H. pylori IgG antibodies, were measured in 21,106 subjects who participated in a health checkup between January 2016 and June 2017. The classification of metabolic syndrome followed the revised National Cholesterol Education Program criteria.

Results

After excluding subjects with a history of H. pylori eradication therapy, or gastric symptoms, the seropositivity of H. pylori was 43.2% in 15,195 subjects. H. pylori-positive participants had significantly higher body mass index (BMI), waist circumference, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and lower high-density lipoprotein (HDL-C) than did seronegative participants (P < 0.05). After adjusting for confounders, high TC, low HDL-C, and high LDL-C were associated with H. pylori seropositivity. Finally, the prevalence of metabolic syndrome was higher in H. pylori-seropositive subjects than in negative ones (27.2% vs. 21.0%, P < 0.05), and H. pylori seropositivity increased the likelihood of metabolic syndrome (OR 1.19, 95% CI 1.09–1.31, P < 0.001) after adjusting for sex, age, BMI, smoking, residence, household income, and education level. However, the association between H. pylori seropositivity and metabolic syndrome disappeared in those ≥ 65 years old.

Conclusions

H. pylori infection plays an independent role in the pathogenesis of metabolic syndrome in Koreans under 65 years old.
Literatur
1.
Zurück zum Zitat McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med. 2010;362:1597–1604.CrossRef McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med. 2010;362:1597–1604.CrossRef
2.
Zurück zum Zitat de Korwin JD, Ianiro G, Gibiino G, Gasbarrini A. Helicobacter pylori infection and extra gastric diseases in 2017. Helicobacter. 2017;22:e12411.CrossRef de Korwin JD, Ianiro G, Gibiino G, Gasbarrini A. Helicobacter pylori infection and extra gastric diseases in 2017. Helicobacter. 2017;22:e12411.CrossRef
3.
Zurück zum Zitat Lim JH, Kim N, Lim SH, Kwon JW, et al. Inverse relationship between Helicobacter pylori infection and asthma among adults younger than 40 years: a cross-sectional study. Medicine (Baltimore). 2016;95:e2609.CrossRef Lim JH, Kim N, Lim SH, Kwon JW, et al. Inverse relationship between Helicobacter pylori infection and asthma among adults younger than 40 years: a cross-sectional study. Medicine (Baltimore). 2016;95:e2609.CrossRef
4.
Zurück zum Zitat Lim SH, Kim N, Kwon JW, Kim SE, et al. Trends in the seroprevalence of Helicobacter pylori infection and its putative eradication rate over 18 years in Korea: a cross-sectional nationwide multicenter study. PLoS One. 2018;13:e0204762.CrossRefPubMedPubMedCentral Lim SH, Kim N, Kwon JW, Kim SE, et al. Trends in the seroprevalence of Helicobacter pylori infection and its putative eradication rate over 18 years in Korea: a cross-sectional nationwide multicenter study. PLoS One. 2018;13:e0204762.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Watanabe S, Hojo M, Nagahara A. Metabolic syndrome and gastrointestinal diseases. J Gastroenterol. 2007;42:267–274.CrossRefPubMed Watanabe S, Hojo M, Nagahara A. Metabolic syndrome and gastrointestinal diseases. J Gastroenterol. 2007;42:267–274.CrossRefPubMed
6.
Zurück zum Zitat Jinjuvadia R, Antaki F, Lohia P, Liangpunsakul S. The association between nonalcoholic fatty liver disease and metabolic abnormalities in the United States population. J Clin Gastroenterol. 2017;51:160–166.CrossRefPubMedPubMedCentral Jinjuvadia R, Antaki F, Lohia P, Liangpunsakul S. The association between nonalcoholic fatty liver disease and metabolic abnormalities in the United States population. J Clin Gastroenterol. 2017;51:160–166.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among US adults: NHANES III to NHANES 1999–2006. Diabetes Care. 2011;34:216–219.CrossRefPubMed Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among US adults: NHANES III to NHANES 1999–2006. Diabetes Care. 2011;34:216–219.CrossRefPubMed
8.
Zurück zum Zitat Nestel P, Lyu R, Low LP, Sheu WH, et al. Metabolic syndrome: recent prevalence in East and Southeast Asian populations. Asia Pac J Clin Nutr. 2007;16:362–367.PubMed Nestel P, Lyu R, Low LP, Sheu WH, et al. Metabolic syndrome: recent prevalence in East and Southeast Asian populations. Asia Pac J Clin Nutr. 2007;16:362–367.PubMed
9.
Zurück zum Zitat Lim S, Shin H, Song JH, Kwak SH, et al. Increasing prevalence of metabolic syndrome in Korea: the Korean national health and nutrition examination survey for 1998–2007. Diabetes Care. 2011;34:1323–1328.CrossRefPubMedPubMedCentral Lim S, Shin H, Song JH, Kwak SH, et al. Increasing prevalence of metabolic syndrome in Korea: the Korean national health and nutrition examination survey for 1998–2007. Diabetes Care. 2011;34:1323–1328.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Tran BT, Jeong BY, Oh JK. The prevalence trend of metabolic syndrome and its components and risk factors in Korean adults: results from the Korean National Health and nutrition examination survey 2008–2013. BMC Public Health. 2017;17:71.CrossRefPubMedPubMedCentral Tran BT, Jeong BY, Oh JK. The prevalence trend of metabolic syndrome and its components and risk factors in Korean adults: results from the Korean National Health and nutrition examination survey 2008–2013. BMC Public Health. 2017;17:71.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Lee SE, Han K, Kang YM, Kim S-O, et al. Trends in the prevalence of metabolic syndrome and its components in South Korea: findings from the Korean National Health Insurance Service Database (2009–2013). PLoS ONE. 2018;13:e0194490.CrossRefPubMedPubMedCentral Lee SE, Han K, Kang YM, Kim S-O, et al. Trends in the prevalence of metabolic syndrome and its components in South Korea: findings from the Korean National Health Insurance Service Database (2009–2013). PLoS ONE. 2018;13:e0194490.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Gunji T, Matsuhashi N, Sato H, Fujibayashi K, et al. Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population. Am J Gastroenterol. 2008;103:3005–3010.CrossRefPubMed Gunji T, Matsuhashi N, Sato H, Fujibayashi K, et al. Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population. Am J Gastroenterol. 2008;103:3005–3010.CrossRefPubMed
14.
Zurück zum Zitat Chen LW, Chien CY, Yang KJ, Kuo SF, Chen CH, Chien RN. Helicobacter pylori Infection increases insulin resistance and metabolic syndrome in residents younger than 50 years old: a community-based study. PLoS ONE. 2015;10:e0128671.CrossRefPubMedPubMedCentral Chen LW, Chien CY, Yang KJ, Kuo SF, Chen CH, Chien RN. Helicobacter pylori Infection increases insulin resistance and metabolic syndrome in residents younger than 50 years old: a community-based study. PLoS ONE. 2015;10:e0128671.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Naja F, Nasreddine L, Hwalla N, Moghames P, et al. Association of H. pylori infection with insulin resistance and metabolic syndrome among Lebanese adults. Helicobacter. 2012;17:444–451.CrossRefPubMed Naja F, Nasreddine L, Hwalla N, Moghames P, et al. Association of H. pylori infection with insulin resistance and metabolic syndrome among Lebanese adults. Helicobacter. 2012;17:444–451.CrossRefPubMed
16.
Zurück zum Zitat Takeoka A, Tayama J, Yamasaki H, Kobayashi M, et al. Impact of Helicobacter pylori immunoglobulin G levels and atrophic gastritis status on risk of metabolic syndrome. PLoS ONE. 2016;11:e0166588.CrossRefPubMedPubMedCentral Takeoka A, Tayama J, Yamasaki H, Kobayashi M, et al. Impact of Helicobacter pylori immunoglobulin G levels and atrophic gastritis status on risk of metabolic syndrome. PLoS ONE. 2016;11:e0166588.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Lim SH, Kwon JW, Kim N, Kim GH, et al. Prevalence and risk factors of Helicobacter pylori infection in Korea: nationwide multicenter study over 13 years. BMC Gastroenterol. 2013;13:104.CrossRefPubMedPubMedCentral Lim SH, Kwon JW, Kim N, Kim GH, et al. Prevalence and risk factors of Helicobacter pylori infection in Korea: nationwide multicenter study over 13 years. BMC Gastroenterol. 2013;13:104.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Kim SY, Ahn JS, Ha YJ, Doh HJ, et al. Serodiagnosis of Helicobacter pylori infection in Korean patients using enzyme-linked immunosorbent assay. J Immunoassay. 1998;19:251–270.CrossRefPubMed Kim SY, Ahn JS, Ha YJ, Doh HJ, et al. Serodiagnosis of Helicobacter pylori infection in Korean patients using enzyme-linked immunosorbent assay. J Immunoassay. 1998;19:251–270.CrossRefPubMed
19.
Zurück zum Zitat Kim JH, Kim HY, Kim N, Kim SW, et al. Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea. J Gastroenterol Hepatol. 2001;16:969–975.CrossRefPubMed Kim JH, Kim HY, Kim N, Kim SW, et al. Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea. J Gastroenterol Hepatol. 2001;16:969–975.CrossRefPubMed
20.
Zurück zum Zitat Yim JY, Kim N, Choi SH, Kim YS, et al. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter. 2007;12:333–340.CrossRefPubMed Yim JY, Kim N, Choi SH, Kim YS, et al. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter. 2007;12:333–340.CrossRefPubMed
21.
Zurück zum Zitat Kim N. Part III Diagnosis 8. Serology In: Kim N, editor. Helicobacter pylori. Singapore: Springer; 2016:113–118. Kim N. Part III Diagnosis 8. Serology In: Kim N, editor. Helicobacter pylori. Singapore: Springer; 2016:113–118.
22.
Zurück zum Zitat van Der Ende A, van Der Hulst RWM, Roorda P, Tytgat GNJ, Dankert J. Evaluation of three commercial serological tests with different methodologies to assess Helicobacter pylori infection. J Clin Microbiol. 1999;37:4150–4152.PubMedCentral van Der Ende A, van Der Hulst RWM, Roorda P, Tytgat GNJ, Dankert J. Evaluation of three commercial serological tests with different methodologies to assess Helicobacter pylori infection. J Clin Microbiol. 1999;37:4150–4152.PubMedCentral
23.
Zurück zum Zitat Grundy SM, Cleeman JI, Daniels SR, Donato KA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–2752.CrossRefPubMed Grundy SM, Cleeman JI, Daniels SR, Donato KA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–2752.CrossRefPubMed
25.
Zurück zum Zitat Sung KC, Rhee EJ, Ryu SH, Beck SH. Prevalence of Helicobacter pylori infection and its association with cardiovascular risk factors in Korean adults. Int J Cardiol. 2005;102:411–417.CrossRefPubMed Sung KC, Rhee EJ, Ryu SH, Beck SH. Prevalence of Helicobacter pylori infection and its association with cardiovascular risk factors in Korean adults. Int J Cardiol. 2005;102:411–417.CrossRefPubMed
26.
Zurück zum Zitat Nam SY, Ryu KH, Park BJ, Park S. Effects of Helicobacter pylori infection and its eradication on lipid profiles and cardiovascular diseases. Helicobacter. 2015;20:125–132.CrossRefPubMed Nam SY, Ryu KH, Park BJ, Park S. Effects of Helicobacter pylori infection and its eradication on lipid profiles and cardiovascular diseases. Helicobacter. 2015;20:125–132.CrossRefPubMed
27.
Zurück zum Zitat Kim TJ, Lee H, Kang M, Kim JE, et al. Helicobacter pylori is associated with dyslipidemia but not with other risk factors of cardiovascular disease. Sci Rep. 2016;6:38015.CrossRefPubMedPubMedCentral Kim TJ, Lee H, Kang M, Kim JE, et al. Helicobacter pylori is associated with dyslipidemia but not with other risk factors of cardiovascular disease. Sci Rep. 2016;6:38015.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Wald NJ, Law MR, Morris JK, Bagnall AM. Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. BMJ. 1997;315:1199–1201.CrossRefPubMedPubMedCentral Wald NJ, Law MR, Morris JK, Bagnall AM. Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. BMJ. 1997;315:1199–1201.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Niemelä S, Karttunen T, Korhonen T, Läärä E, et al. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart. 1996;75:573–575.CrossRefPubMedPubMedCentral Niemelä S, Karttunen T, Korhonen T, Läärä E, et al. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart. 1996;75:573–575.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Chen TP, Hung HF, Chen MK, Lai HH, et al. Helicobacter pylori infection is positively associated with metabolic syndrome in Taiwanese adults: a cross-sectional study. Helicobacter. 2015;20:184–191.CrossRefPubMed Chen TP, Hung HF, Chen MK, Lai HH, et al. Helicobacter pylori infection is positively associated with metabolic syndrome in Taiwanese adults: a cross-sectional study. Helicobacter. 2015;20:184–191.CrossRefPubMed
31.
Zurück zum Zitat Shin DW, Kwon HT, Kang JM, Park JH, et al. Association between metabolic syndrome and Helicobacter pylori infection diagnosed by histologic status and serological status. J Clin Gastroenterol. 2012;46:840–845.CrossRefPubMed Shin DW, Kwon HT, Kang JM, Park JH, et al. Association between metabolic syndrome and Helicobacter pylori infection diagnosed by histologic status and serological status. J Clin Gastroenterol. 2012;46:840–845.CrossRefPubMed
32.
Zurück zum Zitat Polyzos SA, Kountouras J, Zavos C, Deretzi G. The association between Helicobacter pylori infection and insulin resistance: a systematic review. Helicobacter. 2011;16:79–88.CrossRefPubMed Polyzos SA, Kountouras J, Zavos C, Deretzi G. The association between Helicobacter pylori infection and insulin resistance: a systematic review. Helicobacter. 2011;16:79–88.CrossRefPubMed
34.
Zurück zum Zitat Park MJ, Choi SH, Kim D, Kang SJ, et al. Association between Helicobacter pylori seropositivity and the coronary artery calcium score in a screening population. Gut Liver. 2011;5:321–327.CrossRefPubMedPubMedCentral Park MJ, Choi SH, Kim D, Kang SJ, et al. Association between Helicobacter pylori seropositivity and the coronary artery calcium score in a screening population. Gut Liver. 2011;5:321–327.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Gallin JI, Kaye D, O’Leary WM. Serum lipids in infection. N Engl J Med. 1969;281:1081–1086.CrossRefPubMed Gallin JI, Kaye D, O’Leary WM. Serum lipids in infection. N Engl J Med. 1969;281:1081–1086.CrossRefPubMed
36.
Zurück zum Zitat Feingold KR, Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes. 1992;41:97–101.CrossRefPubMed Feingold KR, Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes. 1992;41:97–101.CrossRefPubMed
37.
Zurück zum Zitat Memon RA, Grunfeld C, Moser AH, Feingold KR. Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology. 1993;132:2246–2253.CrossRefPubMed Memon RA, Grunfeld C, Moser AH, Feingold KR. Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology. 1993;132:2246–2253.CrossRefPubMed
38.
Zurück zum Zitat Migneco A, Ojetti V, Specchia L, Franceschi F, et al. Eradication of Helicobacter pylori infection improves blood pressure values in patients affected by hypertension. Helicobacter. 2003;8:585–589.CrossRefPubMed Migneco A, Ojetti V, Specchia L, Franceschi F, et al. Eradication of Helicobacter pylori infection improves blood pressure values in patients affected by hypertension. Helicobacter. 2003;8:585–589.CrossRefPubMed
39.
Zurück zum Zitat Gobert AP, Mersey BD, Cheng Y, Blumberg D, Newton JC, Wilson KT. Cutting edge: urease release by Helicobacter pylori stimulates macrophage inducible nitric oxide synthase. J Immunol. 2002;168:6002–6006.CrossRefPubMed Gobert AP, Mersey BD, Cheng Y, Blumberg D, Newton JC, Wilson KT. Cutting edge: urease release by Helicobacter pylori stimulates macrophage inducible nitric oxide synthase. J Immunol. 2002;168:6002–6006.CrossRefPubMed
40.
Zurück zum Zitat Cammarota G, Figura N, Cianci R, Pasceri V, et al. Is there an antigenic mimicry between arteriosclerotic lesions and H. pylori antigens? Clin Biochem. 2000;33:419–421.CrossRefPubMed Cammarota G, Figura N, Cianci R, Pasceri V, et al. Is there an antigenic mimicry between arteriosclerotic lesions and H. pylori antigens? Clin Biochem. 2000;33:419–421.CrossRefPubMed
41.
Zurück zum Zitat Zhou X, Liu W, Gu M, Zhou H, Zhang G. Helicobacter pylori infection causes hepatic insulin resistance by the c-Jun/miR-203/SOCS3 signaling pathway. J Gastroenterol. 2015;50:1027–1040.CrossRefPubMed Zhou X, Liu W, Gu M, Zhou H, Zhang G. Helicobacter pylori infection causes hepatic insulin resistance by the c-Jun/miR-203/SOCS3 signaling pathway. J Gastroenterol. 2015;50:1027–1040.CrossRefPubMed
43.
Zurück zum Zitat Gillum RF. Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the Third National Health and Nutrition Examination Survey. J Natl Med Assoc. 2004;96:1470–1476.PubMedPubMedCentral Gillum RF. Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the Third National Health and Nutrition Examination Survey. J Natl Med Assoc. 2004;96:1470–1476.PubMedPubMedCentral
44.
Zurück zum Zitat Nabipour I, Vahdat K, Jafari SM, Pazoki R, Sanjdideh Z. The association of metabolic syndrome and Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus type 1: the Persian Gulf Healthy Heart Study. Cardiovasc Diabetol. 2006;5:25.CrossRefPubMedPubMedCentral Nabipour I, Vahdat K, Jafari SM, Pazoki R, Sanjdideh Z. The association of metabolic syndrome and Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus type 1: the Persian Gulf Healthy Heart Study. Cardiovasc Diabetol. 2006;5:25.CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Malamug LR, Karnchanasorn R, Samoa R, Chiu KC. The role of Helicobacter pylori seropositivity in insulin sensitivity, beta cell function, and abnormal glucose tolerance. Scientifica (Cairo). 2014;2014:870165. Malamug LR, Karnchanasorn R, Samoa R, Chiu KC. The role of Helicobacter pylori seropositivity in insulin sensitivity, beta cell function, and abnormal glucose tolerance. Scientifica (Cairo). 2014;2014:870165.
46.
Zurück zum Zitat Gerig R, Ernst B, Wilms B, Thurnheer M, Schultes B. Gastric Helicobacter pylori infection is associated with adverse metabolic traits in severely obese subjects. Obesity (Silver Spring). 2013;21:535–537.CrossRef Gerig R, Ernst B, Wilms B, Thurnheer M, Schultes B. Gastric Helicobacter pylori infection is associated with adverse metabolic traits in severely obese subjects. Obesity (Silver Spring). 2013;21:535–537.CrossRef
47.
Zurück zum Zitat Lee JH, Kim N, Chung JI, Kang KP, et al. Long-term follow up of Helicobacter pylori IgG serology after eradication and reinfection rate of H. pylori in South Korea. Helicobacter. 2008;13:288–294.CrossRefPubMed Lee JH, Kim N, Chung JI, Kang KP, et al. Long-term follow up of Helicobacter pylori IgG serology after eradication and reinfection rate of H. pylori in South Korea. Helicobacter. 2008;13:288–294.CrossRefPubMed
Metadaten
Titel
Positive Association Between Helicobacter pylori Infection and Metabolic Syndrome in a Korean Population: A Multicenter Nationwide Study
verfasst von
Seon Hee Lim
Nayoung Kim
Jin Won Kwon
Sung Eun Kim
Gwang Ho Baik
Ju Yup Lee
Kyung Sik Park
Jeong Eun Shin
Hyun Joo Song
Dae-Seong Myung
Suck Chei Choi
Hyun Jin Kim
Joo Hyun Lim
Jeong Yoon Yim
Joo Sung Kim
Publikationsdatum
09.03.2019
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 8/2019
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05544-3

Weitere Artikel der Ausgabe 8/2019

Digestive Diseases and Sciences 8/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.